Patients | N=141 |
Age in years, median (IQR) | 79 (64 to 85) |
Men, n (%) | 55 (39%) |
Length of stay in days, median (IQR) | 9 (5 to 17) |
Days of surveillance per patient, median (IQR)* | 4 (2 to 7) |
Charlson comorbidity index, n (%) | |
0 points | 42 (30%) |
1–2 points | 64 (45%) |
3–4 points | 22 (16%) |
≥5 points | 13 (9%) |
Comorbidity by condition, n (%) | |
Diabetes mellitus | 33 (23%) |
Cerebrovascular disease | 28 (20%) |
Dementia/cognitive impairment | 25 (18%) |
Heart failure | 20 (14%) |
Coronary disease | 11 (8%) |
Chronic obstructive pulmonary disease | 9 (6%) |
Active cancer | 9 (6%) |
Peripheral vascular disease | 9 (6%) |
*Surveillance duration was shorter than length of stay because patients were transferred on and off the study ward during their hospitalisation.